Related references
Note: Only part of the references are listed.High frequency of clonal hematopoiesis in Erdheim-Chester disease
Fleur Cohen Aubart et al.
BLOOD (2021)
Bone marrow findings in Erdheim-Chester disease: increased prevalence of chronic myeloid neoplasms
Gaurav Goyal et al.
HAEMATOLOGICA (2020)
Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era
Gaurav Goyal et al.
BLOOD (2020)
High prevalence of clonal hematopoiesis in the blood and bone marrow of healthy volunteers
Helene Guermouche et al.
BLOOD ADVANCES (2020)
Concomitant Erdheim-Chester disease and chronic myelomonocytic leukaemia: genomic insights into a common clonal origin
Gaurav Goyal et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
High prevalence of myeloid neoplasms in adults with non-Langerhans cell histiocytosis
Matthias Papo et al.
BLOOD (2017)
Clinical significance of somatic mutation in unexplained blood cytopenia
Luca Malcovati et al.
BLOOD (2017)
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
David P. Steensma et al.
BLOOD (2015)
Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6
Qian Zhang et al.
NATURE (2015)
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Systemic perturbation of cytokine and chemokine networks in Erdheim-Chester disease: a single-center series of 37 patients
Laurent Arnaud et al.
BLOOD (2011)
Share Paper
